nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludrocortisone—AR—scrotum—testicular cancer	0.152	0.324	CbGeAlD
Fludrocortisone—AR—seminiferous tubule of testis—testicular cancer	0.118	0.252	CbGeAlD
Fludrocortisone—AR—semen—testicular cancer	0.0652	0.139	CbGeAlD
Fludrocortisone—Cutaneous hypersensitivity—Chlorambucil—testicular cancer	0.0282	0.0531	CcSEcCtD
Fludrocortisone—Aseptic necrosis—Methotrexate—testicular cancer	0.0187	0.0352	CcSEcCtD
Fludrocortisone—NR3C2—seminal vesicle—testicular cancer	0.0187	0.0399	CbGeAlD
Fludrocortisone—Skin striae—Bleomycin—testicular cancer	0.0168	0.0316	CcSEcCtD
Fludrocortisone—Glucose tolerance impaired—Cisplatin—testicular cancer	0.0146	0.0275	CcSEcCtD
Fludrocortisone—AR—seminal vesicle—testicular cancer	0.0138	0.0295	CbGeAlD
Fludrocortisone—Papilloedema—Cisplatin—testicular cancer	0.0124	0.0233	CcSEcCtD
Fludrocortisone—Trauma—Bleomycin—testicular cancer	0.0112	0.0211	CcSEcCtD
Fludrocortisone—NR3C2—female gonad—testicular cancer	0.011	0.0234	CbGeAlD
Fludrocortisone—NR3C1—embryo—testicular cancer	0.0107	0.0228	CbGeAlD
Fludrocortisone—NR3C1—seminal vesicle—testicular cancer	0.01	0.0214	CbGeAlD
Fludrocortisone—AR—gonad—testicular cancer	0.01	0.0213	CbGeAlD
Fludrocortisone—NR3C2—testis—testicular cancer	0.00973	0.0208	CbGeAlD
Fludrocortisone—Peptic ulcer—Vinblastine—testicular cancer	0.00945	0.0178	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Chlorambucil—testicular cancer	0.00931	0.0175	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Bleomycin—testicular cancer	0.00897	0.0169	CcSEcCtD
Fludrocortisone—AR—female gonad—testicular cancer	0.00812	0.0173	CbGeAlD
Fludrocortisone—Amenorrhoea—Chlorambucil—testicular cancer	0.00785	0.0148	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Ifosfamide—testicular cancer	0.00767	0.0144	CcSEcCtD
Fludrocortisone—NR3C1—gonad—testicular cancer	0.00724	0.0155	CbGeAlD
Fludrocortisone—AR—testis—testicular cancer	0.0072	0.0154	CbGeAlD
Fludrocortisone—NR3C2—lymph node—testicular cancer	0.00705	0.015	CbGeAlD
Fludrocortisone—Diabetic—Methotrexate—testicular cancer	0.00646	0.0122	CcSEcCtD
Fludrocortisone—Optic neuritis—Cisplatin—testicular cancer	0.00639	0.012	CcSEcCtD
Fludrocortisone—Neoplasm—Chlorambucil—testicular cancer	0.00623	0.0117	CcSEcCtD
Fludrocortisone—NR3C1—female gonad—testicular cancer	0.00588	0.0126	CbGeAlD
Fludrocortisone—Optic neuritis—Etoposide—testicular cancer	0.00585	0.011	CcSEcCtD
Fludrocortisone—Osteonecrosis—Methotrexate—testicular cancer	0.00579	0.0109	CcSEcCtD
Fludrocortisone—Neoplasm—Vinblastine—testicular cancer	0.00571	0.0107	CcSEcCtD
Fludrocortisone—Petechiae—Ifosfamide—testicular cancer	0.00554	0.0104	CcSEcCtD
Fludrocortisone—Cardiomegaly—Epirubicin—testicular cancer	0.00553	0.0104	CcSEcCtD
Fludrocortisone—AR—lymph node—testicular cancer	0.00522	0.0111	CbGeAlD
Fludrocortisone—NR3C1—testis—testicular cancer	0.00522	0.0111	CbGeAlD
Fludrocortisone—Amenorrhoea—Ifosfamide—testicular cancer	0.00519	0.00977	CcSEcCtD
Fludrocortisone—Cardiomegaly—Doxorubicin—testicular cancer	0.00512	0.00963	CcSEcCtD
Fludrocortisone—Impaired healing—Methotrexate—testicular cancer	0.00499	0.00939	CcSEcCtD
Fludrocortisone—Infection—Carboplatin—testicular cancer	0.00475	0.00894	CcSEcCtD
Fludrocortisone—Oesophagitis—Dactinomycin—testicular cancer	0.00455	0.00856	CcSEcCtD
Fludrocortisone—Injury—Bleomycin—testicular cancer	0.00421	0.00793	CcSEcCtD
Fludrocortisone—Neoplasm—Ifosfamide—testicular cancer	0.00412	0.00776	CcSEcCtD
Fludrocortisone—Osteoporosis—Methotrexate—testicular cancer	0.00385	0.00724	CcSEcCtD
Fludrocortisone—Hypernatraemia—Epirubicin—testicular cancer	0.00384	0.00723	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Ifosfamide—testicular cancer	0.00382	0.0072	CcSEcCtD
Fludrocortisone—NR3C1—lymph node—testicular cancer	0.00378	0.00807	CbGeAlD
Fludrocortisone—Fluid retention—Cisplatin—testicular cancer	0.00373	0.00702	CcSEcCtD
Fludrocortisone—Multiple fractures—Methotrexate—testicular cancer	0.00371	0.00698	CcSEcCtD
Fludrocortisone—Fracture—Methotrexate—testicular cancer	0.00371	0.00698	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Methotrexate—testicular cancer	0.00363	0.00682	CcSEcCtD
Fludrocortisone—Hypernatraemia—Doxorubicin—testicular cancer	0.00355	0.00669	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Epirubicin—testicular cancer	0.00339	0.00639	CcSEcCtD
Fludrocortisone—Oesophagitis—Etoposide—testicular cancer	0.00329	0.00619	CcSEcCtD
Fludrocortisone—Optic neuritis—Epirubicin—testicular cancer	0.00328	0.00618	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Etoposide—testicular cancer	0.00327	0.00616	CcSEcCtD
Fludrocortisone—Haemoglobin—Vinblastine—testicular cancer	0.00319	0.006	CcSEcCtD
Fludrocortisone—Haemorrhage—Vinblastine—testicular cancer	0.00317	0.00597	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Cisplatin—testicular cancer	0.00315	0.00592	CcSEcCtD
Fludrocortisone—Skin hyperpigmentation—Doxorubicin—testicular cancer	0.00314	0.00591	CcSEcCtD
Fludrocortisone—Optic neuritis—Doxorubicin—testicular cancer	0.00304	0.00571	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Cisplatin—testicular cancer	0.00295	0.00555	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Etoposide—testicular cancer	0.00288	0.00542	CcSEcCtD
Fludrocortisone—Pancreatitis—Ifosfamide—testicular cancer	0.0028	0.00528	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Epirubicin—testicular cancer	0.00273	0.00513	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Etoposide—testicular cancer	0.0027	0.00508	CcSEcCtD
Fludrocortisone—Haemoglobin—Bleomycin—testicular cancer	0.00269	0.00507	CcSEcCtD
Fludrocortisone—Haemorrhage—Bleomycin—testicular cancer	0.00268	0.00504	CcSEcCtD
Fludrocortisone—Petechiae—Methotrexate—testicular cancer	0.00262	0.00493	CcSEcCtD
Fludrocortisone—Convulsion—Chlorambucil—testicular cancer	0.00261	0.00491	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Ifosfamide—testicular cancer	0.00258	0.00486	CcSEcCtD
Fludrocortisone—Dermatitis atopic—Doxorubicin—testicular cancer	0.00252	0.00475	CcSEcCtD
Fludrocortisone—Glycosuria—Epirubicin—testicular cancer	0.00249	0.00469	CcSEcCtD
Fludrocortisone—Vertigo—Vinblastine—testicular cancer	0.00248	0.00467	CcSEcCtD
Fludrocortisone—Petechiae—Epirubicin—testicular cancer	0.00245	0.00462	CcSEcCtD
Fludrocortisone—Infection—Chlorambucil—testicular cancer	0.00244	0.0046	CcSEcCtD
Fludrocortisone—Pancreatitis—Cisplatin—testicular cancer	0.00242	0.00455	CcSEcCtD
Fludrocortisone—Sweating increased—Cisplatin—testicular cancer	0.0024	0.00452	CcSEcCtD
Fludrocortisone—Convulsion—Vinblastine—testicular cancer	0.00239	0.0045	CcSEcCtD
Fludrocortisone—Hypertension—Vinblastine—testicular cancer	0.00238	0.00449	CcSEcCtD
Fludrocortisone—Erythema—Bleomycin—testicular cancer	0.00233	0.00439	CcSEcCtD
Fludrocortisone—Glycosuria—Doxorubicin—testicular cancer	0.00231	0.00434	CcSEcCtD
Fludrocortisone—Haemoglobin—Ifosfamide—testicular cancer	0.0023	0.00433	CcSEcCtD
Fludrocortisone—Amenorrhoea—Epirubicin—testicular cancer	0.0023	0.00432	CcSEcCtD
Fludrocortisone—Haemorrhage—Ifosfamide—testicular cancer	0.00229	0.00431	CcSEcCtD
Fludrocortisone—Petechiae—Doxorubicin—testicular cancer	0.00227	0.00427	CcSEcCtD
Fludrocortisone—Sweating increased—Etoposide—testicular cancer	0.0022	0.00414	CcSEcCtD
Fludrocortisone—Erythema—Dactinomycin—testicular cancer	0.00218	0.00409	CcSEcCtD
Fludrocortisone—Amenorrhoea—Doxorubicin—testicular cancer	0.00213	0.004	CcSEcCtD
Fludrocortisone—Erythema—Ifosfamide—testicular cancer	0.00199	0.00375	CcSEcCtD
Fludrocortisone—Myalgia—Bleomycin—testicular cancer	0.00199	0.00374	CcSEcCtD
Fludrocortisone—Urticaria—Chlorambucil—testicular cancer	0.00195	0.00368	CcSEcCtD
Fludrocortisone—Ecchymosis—Methotrexate—testicular cancer	0.00195	0.00367	CcSEcCtD
Fludrocortisone—Neoplasm—Methotrexate—testicular cancer	0.00195	0.00367	CcSEcCtD
Fludrocortisone—Fluid retention—Epirubicin—testicular cancer	0.00192	0.00361	CcSEcCtD
Fludrocortisone—Oedema—Bleomycin—testicular cancer	0.0019	0.00358	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Bleomycin—testicular cancer	0.0019	0.00358	CcSEcCtD
Fludrocortisone—Infection—Bleomycin—testicular cancer	0.00189	0.00356	CcSEcCtD
Fludrocortisone—Myalgia—Dactinomycin—testicular cancer	0.00185	0.00348	CcSEcCtD
Fludrocortisone—Oesophagitis—Epirubicin—testicular cancer	0.00184	0.00347	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Epirubicin—testicular cancer	0.00183	0.00345	CcSEcCtD
Fludrocortisone—Neoplasm—Epirubicin—testicular cancer	0.00183	0.00343	CcSEcCtD
Fludrocortisone—Ecchymosis—Epirubicin—testicular cancer	0.00183	0.00343	CcSEcCtD
Fludrocortisone—Hypersensitivity—Chlorambucil—testicular cancer	0.00181	0.00341	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Methotrexate—testicular cancer	0.00181	0.0034	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Methotrexate—testicular cancer	0.0018	0.00339	CcSEcCtD
Fludrocortisone—Vertigo—Ifosfamide—testicular cancer	0.00179	0.00337	CcSEcCtD
Fludrocortisone—Oedema—Dactinomycin—testicular cancer	0.00178	0.00334	CcSEcCtD
Fludrocortisone—Fluid retention—Doxorubicin—testicular cancer	0.00177	0.00334	CcSEcCtD
Fludrocortisone—Asthenia—Chlorambucil—testicular cancer	0.00176	0.00332	CcSEcCtD
Fludrocortisone—Infection—Dactinomycin—testicular cancer	0.00176	0.00332	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.00173	0.00326	CcSEcCtD
Fludrocortisone—Convulsion—Ifosfamide—testicular cancer	0.00173	0.00325	CcSEcCtD
Fludrocortisone—Hypertension—Ifosfamide—testicular cancer	0.00172	0.00324	CcSEcCtD
Fludrocortisone—Erythema—Cisplatin—testicular cancer	0.00172	0.00323	CcSEcCtD
Fludrocortisone—Oesophagitis—Doxorubicin—testicular cancer	0.00171	0.00321	CcSEcCtD
Fludrocortisone—Rash maculo-papular—Doxorubicin—testicular cancer	0.0017	0.00319	CcSEcCtD
Fludrocortisone—Myalgia—Ifosfamide—testicular cancer	0.0017	0.00319	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Epirubicin—testicular cancer	0.00169	0.00319	CcSEcCtD
Fludrocortisone—Neoplasm—Doxorubicin—testicular cancer	0.00169	0.00318	CcSEcCtD
Fludrocortisone—Ecchymosis—Doxorubicin—testicular cancer	0.00169	0.00318	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Epirubicin—testicular cancer	0.00168	0.00317	CcSEcCtD
Fludrocortisone—Hypersensitivity—Vinblastine—testicular cancer	0.00166	0.00312	CcSEcCtD
Fludrocortisone—Vascular purpura—Epirubicin—testicular cancer	0.00164	0.00308	CcSEcCtD
Fludrocortisone—Oedema—Ifosfamide—testicular cancer	0.00163	0.00306	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Ifosfamide—testicular cancer	0.00163	0.00306	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Methotrexate—testicular cancer	0.00162	0.00304	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.00162	0.00304	CcSEcCtD
Fludrocortisone—Asthenia—Vinblastine—testicular cancer	0.00162	0.00304	CcSEcCtD
Fludrocortisone—Infection—Ifosfamide—testicular cancer	0.00162	0.00304	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Epirubicin—testicular cancer	0.00162	0.00304	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Ifosfamide—testicular cancer	0.00157	0.00296	CcSEcCtD
Fludrocortisone—Thrombophlebitis—Doxorubicin—testicular cancer	0.00157	0.00295	CcSEcCtD
Fludrocortisone—Diabetes mellitus—Doxorubicin—testicular cancer	0.00156	0.00293	CcSEcCtD
Fludrocortisone—Purpura—Epirubicin—testicular cancer	0.00152	0.00286	CcSEcCtD
Fludrocortisone—Vascular purpura—Doxorubicin—testicular cancer	0.00152	0.00285	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Epirubicin—testicular cancer	0.00151	0.00285	CcSEcCtD
Fludrocortisone—Urticaria—Bleomycin—testicular cancer	0.00151	0.00285	CcSEcCtD
Fludrocortisone—Cardiac failure congestive—Doxorubicin—testicular cancer	0.0015	0.00281	CcSEcCtD
Fludrocortisone—Convulsion—Cisplatin—testicular cancer	0.00149	0.0028	CcSEcCtD
Fludrocortisone—Mood swings—Methotrexate—testicular cancer	0.00148	0.00279	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.00148	0.00279	CcSEcCtD
Fludrocortisone—Myalgia—Cisplatin—testicular cancer	0.00146	0.00275	CcSEcCtD
Fludrocortisone—Affect lability—Epirubicin—testicular cancer	0.00144	0.00271	CcSEcCtD
Fludrocortisone—Vertigo—Etoposide—testicular cancer	0.00141	0.00266	CcSEcCtD
Fludrocortisone—Headache—Vinblastine—testicular cancer	0.00141	0.00266	CcSEcCtD
Fludrocortisone—Purpura—Doxorubicin—testicular cancer	0.00141	0.00265	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Cisplatin—testicular cancer	0.0014	0.00264	CcSEcCtD
Fludrocortisone—Oedema—Cisplatin—testicular cancer	0.0014	0.00264	CcSEcCtD
Fludrocortisone—Hypersensitivity—Bleomycin—testicular cancer	0.0014	0.00264	CcSEcCtD
Fludrocortisone—Anaphylactoid reaction—Doxorubicin—testicular cancer	0.0014	0.00264	CcSEcCtD
Fludrocortisone—Infection—Cisplatin—testicular cancer	0.00139	0.00262	CcSEcCtD
Fludrocortisone—Mood swings—Epirubicin—testicular cancer	0.00139	0.00261	CcSEcCtD
Fludrocortisone—Asthenia—Bleomycin—testicular cancer	0.00137	0.00257	CcSEcCtD
Fludrocortisone—Convulsion—Etoposide—testicular cancer	0.00136	0.00257	CcSEcCtD
Fludrocortisone—Hypertension—Etoposide—testicular cancer	0.00136	0.00256	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Cisplatin—testicular cancer	0.00136	0.00255	CcSEcCtD
Fludrocortisone—Affect lability—Doxorubicin—testicular cancer	0.00133	0.00251	CcSEcCtD
Fludrocortisone—Pancreatitis—Methotrexate—testicular cancer	0.00133	0.0025	CcSEcCtD
Fludrocortisone—Hypersensitivity—Dactinomycin—testicular cancer	0.00131	0.00246	CcSEcCtD
Fludrocortisone—Muscular weakness—Epirubicin—testicular cancer	0.00129	0.00243	CcSEcCtD
Fludrocortisone—Urticaria—Ifosfamide—testicular cancer	0.00129	0.00243	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Etoposide—testicular cancer	0.00128	0.00242	CcSEcCtD
Fludrocortisone—Mood swings—Doxorubicin—testicular cancer	0.00128	0.00242	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.00128	0.0024	CcSEcCtD
Fludrocortisone—Infection—Etoposide—testicular cancer	0.00128	0.0024	CcSEcCtD
Fludrocortisone—Abdominal distension—Epirubicin—testicular cancer	0.00128	0.0024	CcSEcCtD
Fludrocortisone—Asthenia—Dactinomycin—testicular cancer	0.00127	0.0024	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Etoposide—testicular cancer	0.00124	0.00234	CcSEcCtD
Fludrocortisone—Pancreatitis—Epirubicin—testicular cancer	0.00124	0.00234	CcSEcCtD
Fludrocortisone—Hypersensitivity—Ifosfamide—testicular cancer	0.0012	0.00226	CcSEcCtD
Fludrocortisone—Muscular weakness—Doxorubicin—testicular cancer	0.0012	0.00225	CcSEcCtD
Fludrocortisone—Abdominal distension—Doxorubicin—testicular cancer	0.00118	0.00222	CcSEcCtD
Fludrocortisone—Asthenia—Ifosfamide—testicular cancer	0.00117	0.0022	CcSEcCtD
Fludrocortisone—Pancreatitis—Doxorubicin—testicular cancer	0.00115	0.00216	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Epirubicin—testicular cancer	0.00114	0.00215	CcSEcCtD
Fludrocortisone—Haemoglobin—Methotrexate—testicular cancer	0.00109	0.00205	CcSEcCtD
Fludrocortisone—Haemorrhage—Methotrexate—testicular cancer	0.00108	0.00204	CcSEcCtD
Fludrocortisone—Hyperglycaemia—Doxorubicin—testicular cancer	0.00106	0.00199	CcSEcCtD
Fludrocortisone—Hypersensitivity—Cisplatin—testicular cancer	0.00103	0.00194	CcSEcCtD
Fludrocortisone—Urticaria—Etoposide—testicular cancer	0.00102	0.00192	CcSEcCtD
Fludrocortisone—Haemoglobin—Epirubicin—testicular cancer	0.00102	0.00192	CcSEcCtD
Fludrocortisone—Haemorrhage—Epirubicin—testicular cancer	0.00101	0.00191	CcSEcCtD
Fludrocortisone—Asthenia—Cisplatin—testicular cancer	0.00101	0.00189	CcSEcCtD
Fludrocortisone—Hypersensitivity—Etoposide—testicular cancer	0.000947	0.00178	CcSEcCtD
Fludrocortisone—Erythema—Methotrexate—testicular cancer	0.000943	0.00177	CcSEcCtD
Fludrocortisone—Haemoglobin—Doxorubicin—testicular cancer	0.000943	0.00177	CcSEcCtD
Fludrocortisone—Haemorrhage—Doxorubicin—testicular cancer	0.000938	0.00177	CcSEcCtD
Fludrocortisone—Asthenia—Etoposide—testicular cancer	0.000922	0.00173	CcSEcCtD
Fludrocortisone—Erythema—Epirubicin—testicular cancer	0.000883	0.00166	CcSEcCtD
Fludrocortisone—Vertigo—Methotrexate—testicular cancer	0.000847	0.00159	CcSEcCtD
Fludrocortisone—Convulsion—Methotrexate—testicular cancer	0.000817	0.00154	CcSEcCtD
Fludrocortisone—Erythema—Doxorubicin—testicular cancer	0.000817	0.00154	CcSEcCtD
Fludrocortisone—Headache—Etoposide—testicular cancer	0.000805	0.00151	CcSEcCtD
Fludrocortisone—Myalgia—Methotrexate—testicular cancer	0.000803	0.00151	CcSEcCtD
Fludrocortisone—Vertigo—Epirubicin—testicular cancer	0.000793	0.00149	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Methotrexate—testicular cancer	0.00077	0.00145	CcSEcCtD
Fludrocortisone—Convulsion—Epirubicin—testicular cancer	0.000765	0.00144	CcSEcCtD
Fludrocortisone—Infection—Methotrexate—testicular cancer	0.000765	0.00144	CcSEcCtD
Fludrocortisone—Hypertension—Epirubicin—testicular cancer	0.000762	0.00143	CcSEcCtD
Fludrocortisone—Myalgia—Epirubicin—testicular cancer	0.000751	0.00141	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Methotrexate—testicular cancer	0.000744	0.0014	CcSEcCtD
Fludrocortisone—Vertigo—Doxorubicin—testicular cancer	0.000734	0.00138	CcSEcCtD
Fludrocortisone—Oedema—Epirubicin—testicular cancer	0.00072	0.00136	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Epirubicin—testicular cancer	0.00072	0.00136	CcSEcCtD
Fludrocortisone—Infection—Epirubicin—testicular cancer	0.000716	0.00135	CcSEcCtD
Fludrocortisone—Convulsion—Doxorubicin—testicular cancer	0.000708	0.00133	CcSEcCtD
Fludrocortisone—Hypertension—Doxorubicin—testicular cancer	0.000705	0.00133	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000701	0.00132	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Epirubicin—testicular cancer	0.000696	0.00131	CcSEcCtD
Fludrocortisone—Insomnia—Methotrexate—testicular cancer	0.000696	0.00131	CcSEcCtD
Fludrocortisone—Myalgia—Doxorubicin—testicular cancer	0.000695	0.00131	CcSEcCtD
Fludrocortisone—Anaphylactic shock—Doxorubicin—testicular cancer	0.000666	0.00125	CcSEcCtD
Fludrocortisone—Oedema—Doxorubicin—testicular cancer	0.000666	0.00125	CcSEcCtD
Fludrocortisone—Infection—Doxorubicin—testicular cancer	0.000662	0.00125	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000656	0.00123	CcSEcCtD
Fludrocortisone—Insomnia—Epirubicin—testicular cancer	0.000651	0.00123	CcSEcCtD
Fludrocortisone—Hyperhidrosis—Doxorubicin—testicular cancer	0.000644	0.00121	CcSEcCtD
Fludrocortisone—Urticaria—Methotrexate—testicular cancer	0.000611	0.00115	CcSEcCtD
Fludrocortisone—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000607	0.00114	CcSEcCtD
Fludrocortisone—Insomnia—Doxorubicin—testicular cancer	0.000603	0.00113	CcSEcCtD
Fludrocortisone—Urticaria—Epirubicin—testicular cancer	0.000572	0.00108	CcSEcCtD
Fludrocortisone—Hypersensitivity—Methotrexate—testicular cancer	0.000567	0.00107	CcSEcCtD
Fludrocortisone—Asthenia—Methotrexate—testicular cancer	0.000552	0.00104	CcSEcCtD
Fludrocortisone—Hypersensitivity—Epirubicin—testicular cancer	0.000531	0.000999	CcSEcCtD
Fludrocortisone—Urticaria—Doxorubicin—testicular cancer	0.000529	0.000996	CcSEcCtD
Fludrocortisone—Asthenia—Epirubicin—testicular cancer	0.000517	0.000972	CcSEcCtD
Fludrocortisone—Hypersensitivity—Doxorubicin—testicular cancer	0.000491	0.000924	CcSEcCtD
Fludrocortisone—Headache—Methotrexate—testicular cancer	0.000482	0.000907	CcSEcCtD
Fludrocortisone—Asthenia—Doxorubicin—testicular cancer	0.000478	0.0009	CcSEcCtD
Fludrocortisone—Headache—Epirubicin—testicular cancer	0.000451	0.000849	CcSEcCtD
Fludrocortisone—Headache—Doxorubicin—testicular cancer	0.000418	0.000786	CcSEcCtD
